Disposition and Metabolism of Benoxaprofen in Laboratory Animals and Man
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
1. The absorption, distribution, metabolism and excretion of benoxaprofen, a novel anti-inflammatory compound, has been studied in the dog, mouse, rat, rabbit, rhesus monkey and man. 2. Benoxaprofen was well absorbed after oral administration of doses of 1 to 10 mg/kg in all six species. Only unchanged drug was detected in plasma. It was extensively bound to plasma proteins, the highest binding occurring in man (99.8%) and rhesus monkey (99.6%). 3. Species differences were observed in the plasma elimination half-life, the longest being in man (33 h). The rat and mouse also had high values (28 and 24 h respectively) whereas in the other species, values were less than 13 h. 4. After an oral dose of [14C]benoxaprofen (20 mg/kg) to female rats, tissue concn. was highest in liver, kidney, lungs, adrenals and ovaries. Tissue distribution in the pregnant rat was identical to the normal female. The compound was found in the foetus but at a concn. lower than in all maternal organs. 5. There was a marked species difference in the route of excretion. In man, rhesus monkey and rabbit, excretion in the urine was a major route, whilst biliary--faecal excretion was the only effective route in the rat and dog. 6. No major metabolic transformation of benoxaprofen was observed. Man and dog excreted the compound predominantly as the ester glucuronide whereas the rat, mouse, rabbit and rhesus monkey excreted a large proportion of the dose unchanged.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Benoxaprofen (Section 7.8) is the clearance-scaling failure proper: human elimination proved far slower than body-weight projection implied, and the drug accumulated dangerously in elderly patients.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [80]
In the citing paper
“The exposure surface that drove hepatic and cutaneous toxicity was therefore a subpopulation phenomenon largely invisible to a development program anchored on rodents, dogs, and young adult human volunteers.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [80]
In the citing paper
“The principal clearance pathway is acyl glucuronidation followed by renal excretion of conjugates, and species differences in UGT-mediated conjugation efficiency, combined with the absence of an analogous renal-handling step in rodents, led to the disproportionate extension of the human half-life [80].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [80]
In the citing paper
“In rats and dogs, the elimination half-life was on the order of single-digit hours, whereas in healthy young adult human volunteers, the half-life extended to approximately 20–30 h, a divergence that simple multi-species body-weight scaling could not have anticipated [80].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [80]
In the citing paper
“Benoxaprofen, a propionic acid NSAID introduced in 1980, was withdrawn worldwide in 1982 following reports of hepatotoxicity and severe photosensitivity, with elderly patients disproportionately represented among fatalities.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [80]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bray, G. A. (1960) · Analytical Biochemistry · doi:10.1016/0003-2697(60)90025-7 · Cited by 7,476
STUDIES ON THE ABSORPTION, DISTRIBUTION AND EXCRETION OF INDOMETHACIN IN VARIOUS SPECIES
Hucker, H. B., Zacchei, A. G., Cox, S. V., Brodie, D. A., & Cantwell, N. H. R. (1966) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27386-4 · Cited by 322
Clinical Pharmacokinetics: (Second of Two Parts)
Greenblatt, D. J., & Koch-Weser, J. (1975) · New England Journal of Medicine · doi:10.1056/nejm197511062931905 · Cited by 272
Cashin, C. H., Dawson, W., & Kitchen, E. A. (1977) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1977.tb11330.x · Cited by 179
Runkel, R., Chaplin, M., Boost, G., Segre, E., & Forchielli, E. (1972) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600610507 · Cited by 172
THE INFLUENCE OF ENTEROHEPATIC CIRCULATION ON TOXICITY OF DRUGS*
Williams, R. T., Millburn, P., & Smith, R. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb12249.x · Cited by 130
2-Aryl-5-benzoxazolealkanoic acid derivatives with notable antiinflammatory activity
DUNWELL, D. W., Evans, D. E., Hicks, T. A., Cashin, C. H., & Kitchen, A. (1975) · Journal of Medicinal Chemistry · doi:10.1021/jm00235a012 · Cited by 53
HEPWORTH, W., Newbould, B. B., PLATT, D. S., & Stacey, G. J. (1969) · Nature · doi:10.1038/221582b0 · Cited by 34
Metabolism of Thiazole Acetic Acid Derivatives and the NIH Shift
FOULKES, D. M. (1969) · Nature · doi:10.1038/221582a0 · Cited by 16
Chatfield, D., Tarrant, M., Smith, G., & Speirs, C. F. (1977) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1977.tb00789.x · Cited by 16
Self-citation
Research works printed but not linked: 1
- Chatfield D. H., 1978, J. Chromatog
Cited by
Hutt, A. J., & Caldwell, J. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb02874.x · Cited by 394
Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications
Shipkova, M., Armstrong, V. W., Oellerich, M., & Wieland, E. (2003) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200302000-00001 · Cited by 267
Relevance of Half-Life in Drug Design: Miniperspective
Smith, D. A., Beaumont, K., Maurer, T. S., & Di, L. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00969 · Cited by 199
Acyl glucuronides: the good, the bad and the ugly
Regan, S. L., Maggs, J. L., Hammond, T. G., Lambert, C., Williams, D. P., & Park, B. K. (2010) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.720 · Cited by 185
“turnover in humans [200] along with a more minor metabolite (2.”
BackgroundBoelsterli, U. A., Zimmerman, H. J., & Kretz-Rommel, A. (1995) · Critical Reviews in Toxicology · doi:10.3109/10408449509089888 · Cited by 180
Metadata
- Authors
- Chatfield, D. H., & Green, J. N.
- Venue
- Xenobiotica
- Publisher
- Informa UK Limited
- Published
- 1978-01
- Volume
- 8
- Issue
- 3
- Pages
- 133-144
- ISSN
- 0049-8254 (ISSN-L)
- 1366-5928
- OpenAlex
- W2018551404
- Cited by
- 52
- References
- 10
- Citations by year
- 2026: 1 · 2024: 1 · 2017: 1 · 2012: 1
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Xenobiotica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
- Keywords
- benoxaprofen, drug disposition, drug metabolism, oral absorption, plasma protein binding, elimination half-life, tissue distribution, species differences, glucuronide conjugates, urinary excretion, biliary excretion, anti-inflammatory agents
- MeSH terms
- Administration, Oral, Animals, Haplorhini, Anti-Inflammatory Agents, Non-Steroidal, Benzoxazoles, Blood Proteins, Dogs, Female, Half-Life, Humans, Injections, Intravenous, Male, Pregnancy, Propionates, Protein Binding, Rabbits, Species Specificity, Tissue Distribution, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disposition and Metabolism of Benoxaprofen in Laboratory Animals and Man. https://app.cochat.ai/papers/10.3109/00498257809060392
- The paper
- Chatfield, D. H., & Green, J. N. (1978). Disposition and Metabolism of Benoxaprofen in Laboratory Animals and Man. Xenobiotica. https://doi.org/10.3109/00498257809060392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.